Vaccine + Durvalumab in Human Papilloma Virus (HPV) Cancers

Conditions:   Malignant Neoplasms of Digestive Organs;   Malignant Neoplasms of Female Genital Organs;   Malignant Neoplasms of Male Genital Organs;   Human Papilloma Virus Interventions:   Biological: MEDI0457;   Drug: Durvalumab;   Procedure: Electroporation Sponsors:   M.D. Anderson Cancer Center;   AstraZeneca;   Inovio Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials